In the pharmaceutical supply chain as whole, many players operating in this market do not have information about prices, which can make informed decision-making difficult and imperfect
Yes, but under different legal conditions
Finan 2013 introduced the dual incretin co-agonist concept that became tirzepatide
Additionally, gastrointestinal side effects, such as nausea, vomiting, and diarrhea, are commonly associated with GLP-1 receptor agonists, especially during the initial phase of treatment
The different methods work synergistically, through the degradation of the toxin, decreasing the active form of the mycotoxin or just binding to the toxin and reducing the free toxin ratio